Stockreport

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF Platform's Potential to Increase Local Drug Potency and Reduce Systemic Exposure and Common Side Effects of Chemotherapy MOUNTAIN VIEW, Calif., April 23, 2026 (GLOBE N [Read more]